Applied Therapeutics, Inc. — Director's Dealing 2019

May 14, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2019-05-13

Reporting Person: Lerner Teena (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9171	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series B Preferred Stock	$		Common Stock (9999)		Direct
Stock Option (right to buy)	$1.00	2027-03-20	Common Stock (18453)		Direct
Stock Option (right to buy)	$4.70	2029-03-17	Common Stock (35911)		Direct

Footnotes

F1: Each share of Series B Preferred Stock is convertible at any time at the option of the holder, without payment of additional consideration, into Common Stock, on a one-for-one basis, has no expiration date and is expected to automatically convert into shares of Common Stock upon the closing of the Issuer's initial public offering.

F2: These options became fully vested on April 22, 2019.

F3: One-third (1/3rd) of the shares subject to the option vested or shall vest on each of March 18, 2019, March 18, 2020 and March 18, 2021, subject to the Reporting Person continuing to provide service through each such date.